Correlation Between NYSE Composite and Teva Pharma

Can any of the company-specific risk be diversified away by investing in both NYSE Composite and Teva Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NYSE Composite and Teva Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between NYSE Composite and Teva Pharma Industries, you can compare the effects of market volatilities on NYSE Composite and Teva Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NYSE Composite with a short position of Teva Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of NYSE Composite and Teva Pharma.

Diversification Opportunities for NYSE Composite and Teva Pharma

-0.62

Correlation Coefficient

NYSE Composite  Teva Pharma

Excellent diversification

The 3 months correlation between NYSE and Teva is -0.62. Overlapping area represents the amount of risk that can be diversified away by holding NYSE Composite and Teva Pharma Industries in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Teva Pharma Industries and NYSE Composite is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NYSE Composite are associated (or correlated) with Teva Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Teva Pharma Industries has no effect on the direction of NYSE Composite i.e., NYSE Composite and Teva Pharma go up and down completely randomly.

Pair Corralation between NYSE Composite and Teva Pharma

Assuming the 90 days trading horizon NYSE Composite is expected to generate 0.33 times more return on investment than Teva Pharma. However, NYSE Composite is 3.02 times less risky than Teva Pharma. It trades about 0.16 of its potential returns per unit of risk. Teva Pharma Industries is currently generating about -0.08 per unit of risk. If you would invest  1,901,742  in NYSE Composite on September 3, 2024 and sell it today you would earn a total of  119,580  from holding NYSE Composite or generate 6.29% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

NYSE Composite  vs.  Teva Pharma Industries

Pair Trading with NYSE Composite and Teva Pharma

The main advantage of trading using opposite NYSE Composite and Teva Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NYSE Composite position performs unexpectedly, Teva Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Teva Pharma will offset losses from the drop in Teva Pharma's long position.

The idea behind NYSE Composite and Teva Pharma Industries pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.